Inhibition of the Phosphatidylinositol-3 Kinase Pathway Using Bimiralisib in Loss-of-Function <i>NOTCH1</i>-Mutant Head and Neck Cancer
Faye M. Johnson(The University of Texas MD Anderson Cancer Center), Mitchell J. Frederick(The University of Texas MD Anderson Cancer Center), Seema Rawal(The University of Texas MD Anderson Cancer Center), Pooja A. Shah(The University of Texas MD Anderson Cancer Center), Hai T. Tran(The University of Texas MD Anderson Cancer Center), Mohamed A. Gouda(The University of Texas MD Anderson Cancer Center), Filip Jankú(The University of Texas MD Anderson Cancer Center), Clark R. Andersen(The University of Texas MD Anderson Cancer Center), Adel K. El‐Naggar(The University of Texas MD Anderson Cancer Center), Jason M. Johnson(Yale University), Jitesh D. Kawedia(The University of Texas MD Anderson Cancer Center), Defeng Deng(Baylor College of Medicine), Debora Schmitz(PIQUR Therapeutics (Switzerland))
Cited by 21
Related Papers
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in <i>NOTCH1</i>
|Science|2011|1.7k
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
|Blood|2016|1.6k
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma
|JAMA Oncology|2016|1.4k
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts
|New England Journal of Medicine|2011|1.2k
Adenovirus-Mediated p53 Gene Transfer in Advanced Non-Small-Cell Lung Cancer
|JNCI Journal of the National Cancer Institute|1999|497